Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M8,299Revenue $M872Net Margin (%)24.8Z-Score3.1
Enterprise Value $M9,263EPS $3.5Operating Margin %39.0F-Score5
P/E(ttm))113Cash Flow Per Share $3.6Pre-tax Margin (%)35.3Higher ROA y-yN
Price/Book7.010-y EBITDA Growth Rate %0Quick Ratio2.0Cash flow > EarningsY
Price/Sales9.25-y EBITDA Growth Rate %68.3Current Ratio2.2Lower Leverage y-yN
Price/Cash Flow14.2y-y EBITDA Growth Rate %-6.1ROA % (ttm)9.7Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)16.7Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M59.4ROI % (ttm)19.6Gross Margin Increase y-yY

Gurus Latest Trades with JAZZ

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
JAZZSteve Mandel 2014-03-31 Buy 1.4%$125.51 - $174.98
$ 139.73-7%New holding, 2344486 sh.2,344,486
JAZZJoel Greenblatt 2014-03-31 Buy 0.02%$125.51 - $174.98
$ 139.73-7%New holding, 7367 sh.7,367
JAZZGeorge Soros 2014-03-31 Buy $125.51 - $174.98
$ 139.73-7%New holding, 3600 sh.3,600
JAZZJohn Paulson 2013-12-31 Sold Out -0.57%$82.62 - $126.79
$ 139.7335%Sold Out0
JAZZJohn Paulson 2012-09-30 Buy 0.47%$44.4 - $58.5
$ 139.73189%New holding, 1000000 sh.1,000,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

JAZZ is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
JAZZ Joel Greenblatt 2014-03-317,3670.010.02New Buy
JAZZ Steve Mandel 2014-03-312,344,4863.951.4New Buy
JAZZ George Soros 2014-03-313,6000.010New Buy
Premium Most recent portfolio changes are included for Premium Members only!

JAZZ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Hooper Suzanne SawochkaEVP and General Counsel 2014-07-08Sell1,853$155-9.85view
Keegan FintanEVP, Technical Operations 2014-07-08Sell1,991$155-9.85view
COZADD BRUCE CChairman and CEO 2014-07-08Sell5,000$155-9.85view
WILSON KAREN JSVP, Finance & PAO 2014-07-07Sell2,500$165-15.32view
Mulligan SeamusDirector 2014-06-25Sell50,000$149.69-6.65view
Cox Russell J.EVP & COO 2014-06-20Sell2,000$155-9.85view
Keegan FintanEVP, Technical Operations 2014-06-17Sell3,750$150-6.85view
COZADD BRUCE CChairman and CEO 2014-06-10Sell5,000$142.34-1.83view
Tobias Jeffrey KEVP, Research & Dev and CMO 2014-06-09Sell3,000$146.24-4.45view
Keegan FintanEVP, Technical Operations 2014-06-09Sell750$146.24-4.45view

Press Releases about JAZZ :

    Quarterly/Annual Reports about JAZZ:

    News about JAZZ:

    Articles On GuruFocus.com
    Weekly CFO Sells Highlight: Google Inc, Jazz Pharmaceuticals PLC, Jack in the Box Inc. Jun 30 2014 
    Weekly Insider Sells Highlight: JAZZ, HD, ESRX, SCI Mar 11 2014 
    Weekly CFO Sells Highlight: Jazz Pharmaceuticals PLC, Carnival PLC, Juniper Networks Inc., Home Depo Mar 10 2014 
    comment on JAZZ Mar 21 2013 
    optimized portfolio Jul 26 2011 
    Jazz Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 08 2011 
    Jazz Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 05 2010 
    Weekly CFO Buys Highlight: JAZZ, VRTB, ASTM, ARWR, CGX Sep 04 2010 
    Jazz Pharmaceuticals Inc. (JAZZ) CFO Kathryn E Falberg buys 50,000 Shares Sep 01 2010 
    Jazz Pharmaceuticals Inc. (JAZZ) CEO Bruce C Cozadd buys 10,000 Shares Sep 01 2010 

    More From Other Websites
    A Cup-With-Handle Breakout Can Lead To Massive Gains Jul 30 2014
    Analysis - Ireland has too much to lose to deter U.S. companies re-homing Jul 30 2014
    CANbridge Life Sciences And EUSA Pharma Form Agreement to Commericalize Caphosol® in China Jul 28 2014
    Jazz Pharmaceuticals to Report 2014 Second Quarter Financial Results on August 5, 2014 Jul 23 2014
    Jazz Pharmaceuticals/Concert Pharmaceuticals Start Study Jul 22 2014
    Jazz Pharmaceuticals to Report 2014 Second Quarter Financial Results on August 5, 2014 Jul 22 2014
    Jazz Pharmaceuticals and Concert Pharmaceuticals Provide a Phase 1 Clinical Trial Update on JZP-386 Jul 21 2014
    Jazz Pharmaceuticals and Concert Pharmaceuticals Provide a Phase 1 Clinical Trial Update on JZP-386 Jul 21 2014
    Irish Stocks Come To Prominence As Taxes Stay Low Jul 14 2014
    Market Slides On European Bank Worries; Gold Stocks Rise Jul 10 2014
    Salix Pharma Stock Falls Despite Tax-Inversion Deal Jul 09 2014
    Concert Pharmaceuticals' Shares Slip Despite Favorable FDA Meeting Jul 09 2014
    Biotech Stock Roundup: Regado Plunges on Study Update, Jazz Gains on Product Acquisition Deal Jul 09 2014
    Raptor Pharmaceuticals CEO to Retire, Appoints Successor Jul 08 2014
    JAZZ PHARMACEUTICALS PLC Files SEC form 8-K, Other Events Jul 08 2014
    Jazz, Novo Among Medicals Showing Healthy Action Jul 07 2014
    Stocks Add To Losses; TAL Education Bucks Weakness Jul 07 2014
    Salix, Jazz Lead As Drugmakers Pace IBD 50 For Week Jul 03 2014
    Jazz Pharmaceuticals to Buy Rights to Defibrotide, Shares Up Jul 03 2014
    Jazz Pharmaceuticals Public Limited Company (JAZZ) in Focus: Stock Moves 6.9% Higher Jul 03 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    Email Hide